疫苗接种的前沿技术：我们仍需要传统疫苗吗？
Perspective Technologies of Vaccination: Do We Still Need Old Vaccines?
作者信息
Isaguliants Maria, Burt Felicity Jane
机构信息
Institute of Microbiology and Virology, Riga Stradins University, LV-1007 Riga, Latvia.
N.F. Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia.
出版信息
Vaccines (Basel). 2022 Jun 2;10(6):891. doi: 10.3390/vaccines10060891.
Abstract
Until December 2019, we were living in the world of successfully functioning vaccines and vaccination programs [...].
摘要
直到2019年12月，我们一直生活在疫苗和疫苗接种计划成功运作的世界里[...]。
相似文献
1
Perspective Technologies of Vaccination: Do We Still Need Old Vaccines?疫苗接种的前沿技术：我们仍需要传统疫苗吗？
Vaccines (Basel). 2022 Jun 2;10(6):891. doi: 10.3390/vaccines10060891.
2
[BCG vaccines for the prevention of tuberculosis in the world].[全球用于预防结核病的卡介苗]
Kekkaku. 1997 Nov;72(11):629-37.
3
Vaccinology in practical perspective.
Dev Biol Stand. 1986;63:5-13.
4
Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.辉瑞/生物科技和牛津/阿斯利康疫苗对沙特阿拉伯全国疫苗接种运动中真实环境下 COVID-19 发病率和死亡率的影响。
Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7185-7191. doi: 10.26355/eurrev_202111_27271.
5
Advances in Vaccines.疫苗进展
Adv Biochem Eng Biotechnol. 2020;171:155-188. doi: 10.1007/10_2019_107.
6
Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.2003年至2006年澳大利亚原住民和托雷斯海峡岛民中的疫苗可预防疾病及疫苗接种覆盖率
Commun Dis Intell Q Rep. 2008 Jun;32 Suppl:S2-67.
7
Environmental factors which can affect the burden of pneumococcal disease and the immune response to pneumococcal vaccines: the need for more precisely delineated vaccine recommendations.影响肺炎球菌病负担和对肺炎球菌疫苗免疫反应的环境因素：需要更明确的疫苗推荐。
Expert Rev Vaccines. 2019 Jun;18(6):587-596. doi: 10.1080/14760584.2019.1607303. Epub 2019 Apr 30.
8
Prophylactic HPV vaccines: current knowledge of impact on gynecologic premalignancies.预防性人乳头瘤病毒疫苗：对妇科癌前病变影响的当前认知
Discov Med. 2010 Jul;10(50):7-17.
9
Recommendations to drive a value-based decision-making on vaccination.关于推动疫苗接种决策的价值导向的建议。
Expert Rev Vaccines. 2022 Mar;21(3):289-296. doi: 10.1080/14760584.2022.2021880. Epub 2022 Jan 4.
10
Seasonal influenza vaccines.季节性流感疫苗
Curr Top Microbiol Immunol. 2009;333:43-82. doi: 10.1007/978-3-540-92165-3_3.
引用本文的文献
1
Molecular Farming for Immunization: Current Advances and Future Prospects in Plant-Produced Vaccines.用于免疫接种的分子农业：植物生产疫苗的当前进展与未来前景
Vaccines (Basel). 2025 Feb 15;13(2):191. doi: 10.3390/vaccines13020191.
2
Challenges and Opportunities in the Process Development of Chimeric Vaccines.嵌合疫苗工艺开发中的挑战与机遇
Vaccines (Basel). 2023 Dec 8;11(12):1828. doi: 10.3390/vaccines11121828.
本文引用的文献
1
mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2.mRNA 疫苗：如何应对 SARS-CoV-2 的挑战。
Front Immunol. 2022 Jan 21;12:821538. doi: 10.3389/fimmu.2021.821538. eCollection 2021.
2
Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious Diseases.利用合成DNA和电穿孔技术的最新进展快速开发针对COVID-19和其他新兴传染病的疫苗
Front Med Technol. 2020 Oct 21;2:571030. doi: 10.3389/fmedt.2020.571030. eCollection 2020.
3
Immunogenicity of a DNA-Based Sindbis Replicon Expressing Crimean-Congo Hemorrhagic Fever Virus Nucleoprotein.表达克里米亚-刚果出血热病毒核蛋白的基于DNA的辛德毕斯复制子的免疫原性
Vaccines (Basel). 2021 Dec 16;9(12):1491. doi: 10.3390/vaccines9121491.
4
Current state of Ebola virus vaccines: A snapshot.埃博拉病毒疫苗的现状：简要概述
PLoS Pathog. 2021 Dec 9;17(12):e1010078. doi: 10.1371/journal.ppat.1010078. eCollection 2021 Dec.
5
Alphavirus-Driven Interferon Gamma (IFNg) Expression Inhibits Tumor Growth in Orthotopic 4T1 Breast Cancer Model.甲病毒驱动的γ干扰素（IFNg）表达抑制原位4T1乳腺癌模型中的肿瘤生长。
Vaccines (Basel). 2021 Oct 27;9(11):1247. doi: 10.3390/vaccines9111247.
6
Alum Pickering Emulsion as Effective Adjuvant to Improve Malaria Vaccine Efficacy.明矾皮克林乳液作为提高疟疾疫苗效力的有效佐剂
Vaccines (Basel). 2021 Oct 26;9(11):1244. doi: 10.3390/vaccines9111244.
7
The way of SARS-CoV-2 vaccine development: success and challenges.SARS-CoV-2 疫苗的研发之路：成功与挑战。
Signal Transduct Target Ther. 2021 Nov 9;6(1):387. doi: 10.1038/s41392-021-00796-w.
8
Controlled Human Infection Studies: Proposals for guidance on how to design, develop and produce a challenge strain.受控人体感染研究：设计、开发和生产挑战株的指导意见草案。
Biologicals. 2021 Nov;74:16-23. doi: 10.1016/j.biologicals.2021.09.002. Epub 2021 Oct 5.
9
Immunization Against Poliomyelitis and the Challenges to Worldwide Poliomyelitis Eradication.脊髓灰质炎免疫与全球消灭脊髓灰质炎的挑战。
J Infect Dis. 2021 Sep 30;224(12 Suppl 2):S398-S404. doi: 10.1093/infdis/jiaa622.
10
The tangled history of mRNA vaccines.信使核糖核酸疫苗的复杂历史。
Nature. 2021 Sep;597(7876):318-324. doi: 10.1038/d41586-021-02483-w.
Zotero 插件